• Welcome to Tamil Brahmins forums.

    You are currently viewing our boards as a guest which gives you limited access to view most discussions and access our other features. By joining our Free Brahmin Community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, join our community today!

    If you have any problems with the registration process or your account login, please contact contact us.

shocking

drsundaram

Active member
shocking to know the study on the medical doctors degradation
doctor.jpg
 
A lawless industry.... no check ... who will bell the cat..?

There's an unhealthy alliance between doctors and pharma firms

The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs

1575023252167.png




It’s a clear case of self-regulation gone wrong. That some pharmaceutical companies give expensive gifts, distribute cash and pay for extravagant pleasure trips of doctors willing to push their products, is no news. What’s alarming is that there is no law to punish those guilty of the unethical practice; and the government refuses to blink. Result: patients are forced to buy costly medicines.

Companies ramp up drug prices to recover the amount spent on promotion. It was, therefore, no surprise when on January 8, 2019, KC Ramamurthy, Congress MP from Karnataka, demanded in the Rajya Sabha a list of firms accused of bribing doctors and the action taken against them. The government’s response was ambiguous.

Minister of State for Health and Family Welfare Ashwini Choubey said, “The Department of Pharmaceuticals (DoP) has received some complaints against some pharmaceutical companies on unethical marketing practices.” He conveniently ignored the first part of the question.

………………………….

McKinsey & Company, a US management consulting firm, states the Indian pharmaceuticals market is set to grow from $33 billion, according to India Brand Equity Foundation, to $55 billion by 2020 and become comparable with all developed markets other than the US, Japan and China. Small wonder, pharma firms completely ignore UCPMP and promote their products as a business. “The drug promoted the most becomes costliest,” says Chatterjee.

The gifts, however small, influence the physician, states a study conducted in 2013 by Roshni Narendran of the University of Wollongong, Australia, and M Narendranathan of the Kerala Institute of Medical Sciences, Thiruvananthapuram. When a physician listens to a drug salesperson and accepts gifts from the company, the doctor is under obligation to prescribe that drug, the study states.

An analysis by the Economic Times Intelligence Group shows 10 largest pharma firms had spent six per cent of their total sales between April 2003 and March 2004 on research and development. In contrast, these firms spent 290 per cent more on marketing.

Clearly, self-regulation has failed to police the interactions between the physician and the pharma firms. “We had given an alternate law which made regulatory obligations mandatory and not voluntary. It clearly gave penal provisions, from a fine of Rs 50,000 to Rs 20 lakhs and imprisonment depending upon the violation. If such measures are not adopted, this sector will never be regulated,” says Guha.

Read more at:

 

Latest ads

Back
Top